The recent development of transgenic rodent lines expressing cre recombinase in a cell-specific manner, along with advances in engineered viral vectors, has permitted in-depth investigations into circuit function. However, emerging evidence has begun to suggest that genetic modifications may introduce unexpected caveats. In the current studies, we sought to extensively characterize male and female mice from both the ChAT ( 
Introduction
The generation of transgenic, knock-in, and knock-out rodent lines has led to significant advances in our understanding of the mechanisms mediating normal and disease-relevant physiological function. Indeed, given the recent development of transgenic rodent lines expressing cre recombinase in a cell-specific manner, a vast number of strains with varying gene promoters have become a desirable resource for investigations into circuit function (Fowler and Kenny, 2012; Nair et al., 2013) . In the GENSAT database alone, expression profiles can be found for 238 of 289 developed cre lines (GENSAT, 2017) . Recent studies into circuit function have integrated these cre driver lines with optogenetic or chemicogenetic methods across fields to study learning, memory, sleep, circadian cycle, olfactory signaling, emotional states, and motivated behaviors (Yasuda and Mayford, 2006; Liu et al., 2015; Smith et al., 2015; Van Dort et al., 2015; Xu et al., 2015; Caggiano et al., 2016; Roseberry et al., 2016; Zant et al., 2016) .
However, emerging evidence has begun to suggest that the method of development may introduce unexpected phenotypic variation into some mouse lines. For instance, the channelrhodopsin-expressing ChATChR2-EYFP transgenic line has been shown to exhibit attentional deficits, altered learning and memory processing, and enhanced motor endurance, all of which were attributed to overexpression of functional vesicular acetylcholine transporter (VAChT), leading to increased baseline cholinergic tone (Kolisnyk et al., 2013) . Subsequent studies with these mice have demonstrated increased amphetamineinduced stereotypy, age-related motor effects, and neuromuscular junction structural deficits (Crittenden et al., 2014; Sugita et al., 2016) . Thus, data derived from studies examining neural function with this line may be confounded due to the abnormal physiological state.
Although transgenic rodent models have opened up investigations into systems that were previously inaccessible due to methodological limitations, such as with genetic manipulations resulting in early lethality or gross phenotypic effects (Gong et al., 2007; Fowler and Kenny, 2012) , extensive characterization of each rodent line within a novel system must be undertaken to ensure that valid conclusions can be drawn from experimental findings. In the current investigations, we sought to characterize the widely used ChAT-Cre mouse lines: ChAT (BAC) -Cre and ChAT (IRES) -Cre. In generating the ChAT (BAC) -Cre mice, a large construct with fragments of genomic DNA were used to target cre expression GENSAT, 2017 (Ting and Feng, 2014) . The clones were then engineered in bacterial host cells for subsequent integration into the genome via random integration. Although the DNA insert has been considered to be advantageous with respect to limiting transgene silencing or mosaic expression (Bian and Belmont, 2010) , other aspects of this method may introduce experimental limitations, such as variable expression patterns across generations or overexpression of alternate genes found within the bacterial artificial chromosome (BAC) vector. The choline acetyltransferase (ChAT) BAC clone currently available, which was used to generate the ChAT (BAC) -Cre GM60 mouse line in the current study, contains several other genes in the vector, including the VAChT gene Slc18a3, and this same BAC ID (RP23-246B12) was used to generate the ChAT (BAC) -Cre mouse lines GM24 and GM53 and the recombinase driver ChAT-Cre rat line (Gong et al., 2007; Witten et al., 2011; Ting and Feng, 2014) . Moreover, the EGFP reporter and channelrhodopsin ChAT lines similarly contain Slc18a3, although a different BAC clone was used (Gong et al., 2003; Tallini et al., 2006; Zhao et al., 2011; Ting and Feng, 2014) . Given the limitations of the BAC method, novel approaches have been introduced to more specifically target cre expression. In the internal ribosome entry site (IRES) method, the IRES-Cre sequence has been inserted downstream of the ChAT gene promotor to generate ChAT (IRES) -Cre mice (Rossi et al., 2011) . This vector contains the IRES-linked cre gene and frt-flanked neomycin resistance cassette, but not any other genes, and thus should theoretically result in unaltered ChAT expression. In the current studies, we provide evidence that transgenic mice from both the ChAT (BAC) -Cre and ChAT (IRES) -Cre mouse lines have significant differences in baseline and/or nicotine-mediated behaviors, which may be attributed to altered cholinergic and/or cre-mediated effects.
Materials and Methods

Animals
Male and female mice were derived from breeders in our laboratory animal facilities. ChAT (BAC) -Cre mice were originally obtained from the MMRRC (Strain B6.FVB(Cg)-Tg(Chat-cre)GM60Gsat/Mmucd; https://www.mmrrc. org/catalog/sds.php?mmrrc_idϭ30869; RRID:MMRRC_030869-UCD) and bred as transgenic ϫ wild-type mating pairs. ChAT (IRES) -Cre mice were obtained from The Jackson Laboratory (B6;129S6-Chat tm2(cre)Lowl /J; https://www. jax.org/strain/006410; RRID:IMSR_JAX:006410) and bred as hemizygous ϫ hemizygous mating pairs. For these studies, both lines had been backcrossed onto the C57BL/6J background for at least 10 generations. Experimental subjects in all studies consisted of littermates (e.g., wild-type or transgenic littermates of the ChAT (BAC) -Cre line, and wild-type, hemizygous or transgenic littermates of the ChAT (IRES) -Cre line). To further examine the profile of cre expression, both lines were crossed to the ROSA 26Sor -tdTomato reporter line from The Jackson Laboratory (Strain B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato) Hze/J; https://www.jax.org/strain/007914; RRID:IMSR_JAX:007914) for subsequent visualization of cre-expressing cells.
Experimental mice (ϳ2-5 months of age) were maintained in an environmentally controlled vivarium on a 12 h reversed light/dark cycle. Food and water were provided ad libitum until behavioral training commenced. During self-administration procedures, subjects were food restricted to 85-90% of their free-feeding bodyweight, and water was provided ad libitum. All procedures were conducted in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of California, Irvine. 
Genotyping
Around 21 d of age, pups were weaned, and tails were clipped for genetic analysis. Subjects were genotyped with the following primers: ChAT (BAC) -Cre: 5Ј-GGT CTC CTT GTG GAG TGG GAG T-3Ј (Transgenic Forward), 5Ј-CGG CAA ACG GAC AGA AGC ATT-3Ј (Transgenic Reverse); ChAT (IRES) -Cre: 5Ј-GTT TGC AGA AGC GGT GGG-3Ј (Wildtype Forward), 5Ј-CCT TCT ATC GCC TTC TTG ACG-3Ј (Mutant Forward), 5Ј-AGA TAG ATA ATG AGA GGC TC-3Ј (Common Reverse); Rosa-TdTomato 5Ј-AAG GGA GCT GCA GTG GAG TA-3Ј (Wild-type Forward), 5Ј-CCG AAA ATC TGT GGG AAG TC-3Ј (Wildtype Reverse), 5Ј-CTG TTC CTG TAC GGC ATG G-3Ј (Mutant Forward), 5Ј-GGC ATT AAA GCA GCG TAT CC-3Ј (Mutant Reverse).
Drugs
(-)-Nicotine hydrogen tartrate salt (MP Biomedical, catalog #0215355491) was dissolved in 0.9% sterile saline, pH 7.4. Doses of nicotine refer to the free-base form.SCH23390(TocrisBioscience,catalog#0925)wasdissolvedin0.9%sterile saline. Subcutaneous and intraperitoneal injections were administered at a volume of 10 ml/kg.
Experimental design and statistical analyses
Open-field assessment. Male and female mice were first examined for differences in general home-cage behavior and bodyweight (ChAT (BAC) -Cre: n ϭ 7-10 per sex per genotype; ChAT (IRES) -Cre: n ϭ 7 per sex per genotype). Thereafter, the first experimental cohort of male and female subjects (ChAT (BAC) -Cre: n ϭ 9 -10 per sex per genotype; ChAT (IRES) -Cre: n ϭ 8 -14 per sex per genotype) was examined in an open-field chamber for generalized locomotor behavior during a 15 min test. The chamber was composed of Plexiglas (35 cm L ϫ 35 cm W ϫ 31 cm H), and the center and outer-edge zones were designated with the ANY-maze computer software during video analysis. The chamber was enclosed within a black enclosure, and a shielded white light lamp was placed ϳ90 cm above the apparatus for consistent lighting. Before testing, mice were habituated by handling for at least 5 min per day for 2 d. After the baseline locomotor test, a subset of male mice were then examined for nicotine-mediated locomotor effects after a Ն24 h period; additional age-matched subjects for each group were added to this subset to provide sufficient numbers for testing (ChAT (BAC) -Cre: n ϭ 5 per genotype; ChAT (IRES) -Cre: n ϭ 5 per genotype). The cages were placed in the room at least 30 min before testing for acclimation, and thereafter, mice were individually placed into the open field for a 15 min habituation period. Subjects were then injected subcutaneously with either 0.8 mg/kg nicotine or saline control and placed back into the home cage for 15 min. Subjects were then put into the open-field apparatus for a 15 min test. Activity was recorded with a video camera and scored with ANY-maze software.
Elevated plus maze. A second cohort of male mice (ChAT (BAC) -Cre: n ϭ 13-14 per genotype; ChAT (IRES) -Cre: n ϭ 7-8 per genotype) was examined for anxiety-related behavior in the elevated plus maze (EPM) during a 5 min test. The EPM was composed of 4 opaque gray runways 5 cm wide and 35 cm in length, which were elevated 40 cm from the floor. Two opposing closed runways had opaque walls 15 cm in height, whereas the other two opposing sides did not contain walls (open arms). A shielded lamp was placed ϳ60 cm above the center of the maze for consistent lighting. Before testing, mice were habituated by handling for at least 5 min per day for 2 d. On the test day, cages were placed in the room at least 30 min for acclimation. Subjects were all placed in the center portion of the elevated plus maze with their head facing into an open arm of the maze, and behavior was recorded for 5 min thereafter with a video camera. Behavior was scored with ANY-maze software, in which the animal's head was used as the designated point to quantify time in an arm in accordance with the ANY-maze software program settings.
Cataplexy assessment. A third cohort of male mice (ChAT (BAC) -Cre: n ϭ 5-8 per genotype; ChAT (IRES) -Cre: n ϭ 4 -8 per genotype) was examined in the cataplexy bar test as described previously (Kharkwal et al., 2016) . Mice were injected intraperitoneally with SCH 23390 (0.035 mg/kg), a dopamine D1 receptor antagonist, or saline vehicle 30 min before the test session. This lower dose of SCH 23390 was selected based previous findings demonstrating moderate effects in mice (Kharkwal et al., 2016) . During testing, mice were placed with forepaws on a 0.5 cm diameter rod covered with nonslippery tape, which was suspended 5 cm above the bench. The test session was video recorded. The time spent immobile was measured across three consecutive trials, and the cutoff time for each trial was 2.5 min. The mean of the three trials for each subject was used for data analysis.
Food and intravenous nicotine self-administration. A fourth cohort of male and female mice (ChAT (BAC) -Cre: n ϭ 4 -10 per sex per genotype; ChAT (IRES) -Cre: n ϭ 7-11 per sex per genotype) was mildly food restricted to 85-90% of their free-feeding bodyweight and trained to press a lever in an operant chamber (Med Associates) for food pellets (20 mg; TestDiet) under a fixed-ratio 5, time out 20 s (FR5TO20 s) schedule of reinforcement. Once stable responding was achieved (Ͼ25 pellets per session across 3 subsequent sessions), male subjects were surgically catheterized as previously described (Fowler et al., 2011) . Briefly, mice were anesthetized with an isoflurane (1-3%)/oxygen vapor mixture and prepared with intravenous catheters. Catheters consisted of a 6 cm length of Silastic tubing fitted to guide cannula (Plastics One) bent at a curved right angle and encased in dental acrylic. The catheter tubing was passed subcutaneously from the animal's back to the right jugular vein, and a 1 cm length of the catheter tip was inserted into the vein and tied with surgical silk suture. Following the surgical procedure, animals were allowed Ն48 h to recover from surgery, then provided access to respond for food reward. Male subjects (ChAT (BAC) -Cre: n ϭ 5-6 per genotype; ChAT (IRES) -Cre: n ϭ 5-6 per genotype) were then permitted to acquire intravenous nicotine self-administration during 1 h daily sessions, 6 -7 d per week, at the standard training dose of nicotine (0.03 mg/kg/infusion). Based on low responding found in the ChAT (BAC) -Cre Tg mice at the 0.03 mg/kg/infusion training dose, an additional cohort of male mice (n ϭ 14) was provided access to a lower dose of nicotine (0.01 mg/kg/infusion) as the initial training dose. Nicotine was delivered through tubing into the intravenous catheter by a Razel syringe pump (Med Associates). Each session was performed using two retractable levers (1 active, 1 inactive). Completion of the response criteria on the active lever resulted in the delivery of an intravenous nicotine infusion (0.03 ml infusion volume; FR5TO20 s schedule). Responses on the inactive lever were recorded but had no scheduled consequences. Catheters were flushed daily with physiological sterile saline solution (0.9% w/v) containing heparin (100 USP U/ml). Catheter integrity was tested with the ultra short-acting barbiturate anesthetic Brevital (methohexital sodium, Eli Lilly). To ascertain the dose-response function, male mice (ChAT (BAC) -Cre: n ϭ 7-10 per genotype; ChAT (IRES) -Cre: n ϭ 5-7 per genotype) were then tested as described previously (Fowler and Kenny, 2011) . Briefly, following an acquisition period of at least 7 d on the training dose (0.03 mg/kg/infusion), the animals were presented with a different dose of nicotine for at least 5 d, and the mean intake for the last three sessions was used for statistical analyses. In between each dose, subjects were returned to the 0.1 mg/kg/infusion dose for 2 d or until intake returned to baseline levels. Subjects and their data were removed from the study if the catheter integrity was compromised as determined by visual leakage or Brevital assessment. Behavioral responses were automatically recorded by Med Associates software.
RT-qPCR. A fifth cohort of male mice from each genotype (ChAT (BAC) -Cre: n ϭ 5 per genotype; ChAT (IRES) -Cre: n ϭ 10 -12 per genotype) had their brain regions immediately microdissected, placed in a collection tube and flash frozen. All tissue was stored at Ϫ80°C until further processing. RNA was extracted from homogenized tissue with Trizol reagent (Ambion Life Technologies) via the manufacturer's protocol. The quality of the RNA was determined by a NanoDrop 2000 spectrophotometer (ThermoFisher Scientific). For each sample, 100 ng of total RNA was reverse transcribed into cDNA with the iScript cDNA synthesis kit (BioRad Laboratories). Quantitative PCR was performed for cre recombinase (cre; Assay Mr00635245_cn, ThermoFisher Scientific) and the housekeeping gene, ␤-actin (ACTB; Assay Mm02619580_g1, ThermoFisher Scientific). TaqMan Universal Master Mix II with real time PCR gene expression assays were used according to the manufacturer's parameters (Applied Biosystems). Samples were tested in duplicate or triplicate and quantified with a CFX96 RT-qPCR system (Bio-Rad). Samples with CT values Ͼ35 cycles were considered outside of the range of inclusion, and thus, these samples were determined to exhibit no expression in the tissue of interest. Normalized gene expression was calculated by dividing the 2 ⌬CT values for each gene of interest by the corresponding ␤-actin value and multiplying by a factor of 100.
Protein expression analysis. Hippocampal ChAT, VAChT, and ␤-actin expression levels were evaluated with Western blot in a sixth cohort of mice; this cohort included male subjects from the EPM test and additional subjects were added to achieve sufficient samples for processing (ChAT Westerns: ChAT (BAC) -Cre, n ϭ 13-15 per genotype; ChAT (IRES) -Cre, n ϭ 8 -12 per genotype; VAChT Westerns: ChAT (BAC) -Cre, n ϭ 10 -12 per genotype; ChAT (IRES) -Cre, n ϭ 5-15 per genotype). Samples were run in duplicate or triplicate, dependent on the amount of protein available. Total protein concentrations were determined using the BCA Protein Assay (ThermoFisher Scientific). Samples of 30 g of protein were run with electrophoresis on 15% precast polyacrylamide gel. Proteins were transferred to nitrocellulose membranes (Bio-Rad). The membranes were blocked for 2 h at 4°C in blocking buffer (containing 5% BSA, 0.1% Tween 20, and 0.01 M tris-buffered saline) followed by primary antibody incubation against VAChT (goat polyclonal antibody, 1:5000 dilution; Santa Cruz Biotechnology, catalog #sc-7717; RRID: AB_2301794), ChAT (goat polyclonal antibody, 1:1000 dilution; EMD Millipore, catalog #AB144P; RRID:AB_2079751), or ␤-actin (mouse monoclonal antibody, 1:7500 dilution; Sigma-Aldrich, catalog #A5316; RRID:AB_476743) overnight at 4°C. The membranes were then incubated with HRP-conjugated donkey anti-goat or anti-mouse IgG secondary antibody (1:10,000 dilution; Jackson ImmunoResearch) for 2 h at room temperature. Membranes were imaged and analyzed via ChemiDoc XRSϩ system and software (Bio-Rad), and protein levels were determined by quantification of the band density for ChAT, VAChT, and ␤-actin. ChAT and VAChT values were normalized to ␤-actin expression. Cre protein expression was also analyzed, but similar bands were found in wild-type and cre-expressing tissue, indicating nonspecific reactivity of the primary antibodies; thus, data are not included. Crerecombinase antibodies tested included: mouse monoclonal (1:1000 dilution; Abcam, catalog #ab24607; RRID:AB_448179), rabbit polyclonal (1:5000; Abcam, catalog #ab188568), and rabbit polyclonal 69050-3 (1:10,000; Novagen/Sigma-Aldrich, catalog# 69050-3; RRID: AB_10806983).
For immunofluorescence analysis, ChAT-Cre::ROSA 26Sor -tdTomato male mice (ChAT (BAC) -Cre, n ϭ 4 -5 per genotype; ChAT (IRES) -Cre, n ϭ 4 -5 per genotype) were anesthetized with ketamine-xylazine and A significant interaction effect was found for session by sex, with females exhibiting lower overall levels of responding for food reward (*p Ͻ 0.0001). For the ChAT (IRES) -Cre mice, all mice achieved the criteria for food training across daily 1 h sessions (b; n ϭ 7-11 per group). However, a main effect of genotype was found with lower levels of responding for ChAT (IRES) -Cre mice Tg/Tg subjects ( ϩ p Ͻ 0.05), and an interaction effect was evident for session by sex with overall lower levels of responding by female subjects across sessions (*p Ͻ 0.01). Data represent mean Ϯ SEM.
perfused through the ascending aorta with 0.9% physiological saline, followed by 4% paraformaldehyde in 0.1 M PBS, pH 7.4. Thereafter, brains were removed and postfixed for 2 h in paraformaldehyde, followed by incubation in 30% sucrose for at least 72 h. Sections were cut on a cryostat at 35 m thickness and stored in 0.1 M PBS. Sections containing the medial septum and dorsal hippocampus were mounted on glass slides and coverslipped with Vectashield containing DAPI (Vector Laboratories). Slides were then examined with a Leica DM4000 fluorescence microscope with the same 20ϫ magnification, gain, and exposure maintained for all imaging of each brain region.
Approach for unbiased data collection. Subjects were genotyped before experimental investigation and provided a subject ID number that did not denote group assignment. This information was retained in a secure database. The animals were then assigned to the experimenters on a cage-by-cage basis for experimental testing; since the mice were littermates, each cage consisted of subjects with varying genotypes (e.g., mice were not housed based on genotype). After all data were collected within each experiment by experimenters blinded to the testing condition, the results were sent to another investigator not involved in the experimental analysis for decoding and statistical analyses. Each behavior was scored by two blinded experimenters to provide further confidence in the findings. In the event that a drug injection was known to the experimenter performing the behavioral test, other blinded experimenters completed the data quantification/analysis. When possible, ANY-maze software was used to analyze the data to provide an additional level of objective behavioral assessment.
Statistical analyses. Data were analyzed by a t test, one-way, two-way, or three-way ANOVA using GraphPad Prism or IBM SPSS software, as appropriate. Significant main or interaction effects were followed by Bonferroni or Sidak post hoc comparison with correction for multiple comparisons. The criterion for significance was set at ␣ ϭ 0.05.
Results
General characteristics
Mice were first examined for differences in general home-cage behavior and bodyweight. Subjects did not differ in any notable subjective measures (activity, grooming, appearance). When examined for bodyweight, the ChAT (BAC) -Cre wild-type (Wt) and transgenic (Tg) mice exhibited similar free-feeding bodyweights Locomotor, cataplexy, and anxiety-related behaviors Baseline differences in locomotor activity in the open field were examined across genotypes (Fig. 1) . Male and female ChAT (BAC) -Cre Wt and Tg mice did not significantly differ in distance traveled ( Fig. 1a; Fig. 1f ; one-way ANOVA: F (2,21) ϭ 1.28, p ϭ 0.301). These findings further support the center time findings from the open field, with no phenotypic differences in anxiety-like behavior among the groups.
Next, male mice were examined for behavioral inhibition (cataplexy) following administration of SCH 23390, a selective D1 dopamine receptor antagonist. ChAT (BAC) -Cre (Fig. 2a) and ChAT (IRES) -Cre (Fig. 2c) mice exhibited similar behavioral inhibition with a statistically significant increase in cataplexy following drug treatment, but no main effect of genotype or interaction were found (ChAT (BAC) -Cre, one-way ANOVA: Genotype: the Wt/Wt group), further confirming the overall lowered baseline level of activity in this group. Nicotine-induced hypolocomotion was found in the Wt/Wt mice compared with their respective vehicle value ( p Ͻ 0.001). However, both the Tg/Wt and Tg/Tg mice did not statistically differ in distance traveled following nicotine administration, which could potentially have been due to a floor effect for locomotor behavior and/or a decreased physiological response to nicotine.
Learning-and memory-related behaviors
To assess the ability to learn an operant response to obtain food reward, the mouse lines were examined for food selfadministration contingent on lever pressing behavior (Fig. 3) . Both males and females were included in these assessments. ChAT (BAC) -Cre mice exhibited a significant interaction across sessions for sex ( Fig. 3a; three-way repeated-measures ANOVA (sphericity assumed): Genotype: F (1,27) ϭ 2.01, p ϭ 0.168; Sex: F (1,27) ϭ 23.18, p ϭ 0.000; Genotype ϫ Sex Interaction: F (1,27) ϭ 2.42, p ϭ 0.131; Session: F (6,162) ϭ 101.17, p ϭ 0.000; Session ϫ Genotype Interaction: F (6,162) ϭ 1.57, p ϭ 0.159; Session ϫ Sex Interaction: F (6,162) ϭ 6.33, p ϭ 0.000; Session ϫ Genotype ϫ Sex Interaction: F (6,162) ϭ 0.20, p ϭ 0.975). Whereas the groups exhibited similar acquisition during the initial training sessions, the female mice demonstrated an overall lower level of lever pressing for food pellets than males across days. For the ChAT (IRES) -Cre mice, the Tg/Tg group appeared to require an increased number of sessions to achieve a similar level of responding as the Wt/Wt mice ( Fig. 3b ; three-way repeated-measures ANOVA (sphericity assumed): Genotype: F (2,43) ϭ 4.63, p ϭ 0.015; Sex: F (1,43) ϭ 6.02, p ϭ 0.018; Genotype ϫ Sex Interaction: F (2,43) ϭ 0.55, p ϭ 0.583; Session: F (6,258) ϭ 95.99, p ϭ 0.000; Session ϫ Genotype Interaction: F (12,258) ϭ 2.30, p ϭ 0.009; Session ϫ Sex Interaction: F (6,258) ϭ 3.35, p ϭ 0.003; Session ϫ Genotype ϫ Sex Interaction: F (12,258) ϭ 0.92, p ϭ 0.527). Post hoc analysis revealed significantly decreased responding of the Tg/Tg group compared with both the Tg/Wt ( p Ͻ 0.05) and Wt/Wt ( p Ͻ 0.01) groups. Of note, all subjects across groups achieved the set criteria for the number of food rewards obtained during the final three sessions (Ͼ25 pellets/session; Fowler and Kenny, 2011), indicating that they all were physically capable of pressing the lever when fully trained and thus did not exhibit extensively gross learning/memory, attentional, or motor deficits.
Nicotine self-administration
Given the sex differences noted above with food training, male subjects were only examined for intravenous nicotine self-administration. ChAT (BAC) -Cre mice were first examined for lever pressing behavior with the standard training dose of nicotine (0.03 mg/kg/infusion; Fig. 4a,b) . ChAT (BAC) -Cre Tg mice attenuated their responding across nicotine sessions, whereas their Wt littermates sustained stable lever pressing for the active lever associated with nicotine infusions. After achieving stable responding on days 5-7 (Fig. 4c) , Wt mice exhibited a significant preference for the active lever, whereas the Tg mice displayed no lever preference (two-way repeated-measures ANOVA: Genotype: F (1,18) ϭ 10.14, p ϭ 0.005; Lever: F (1, 18) ϭ 23.02, p ϭ 0.000; Interaction: F (1,18) ϭ 4.35, p ϭ 0.053). Post hoc tests revealed a significant difference between the Wt active and Wt inactive lever (p Ͻ 0.001), Wt active and Tg active lever (p Ͻ 0.01), and Wt active and Tg inactive lever (p Ͻ 0.001). No statistical difference was found between the Tg active and Tg inactive lever (p Ͼ 0.05). Given that the ChAT (BAC) -Cre Tg mice did not acquire stable intravenous nicotine self-administration behavior on the training dose, we hypothesized that they may be exhibiting an enhanced aversive response to nicotine. Thus, we next examined a separate cohort of ChAT (BAC) -Cre Tg mice with a lower training dose of nicotine (0.01 mg/kg/infusion; Fig. 4d,e) . After transitioning onto nicotine infusions, mice developed relatively more consistent lever-pressing behavior preferentially for the active lever (Fig. 4d ). When these data were analyzed as the mean of the last three sessions, a significant difference was found between responding on the active and inactive lever ( Fig. 4e ; paired t test: t (13) ϭ 3.51, p ϭ 0.004, R 2 ϭ 0.488), although the mean number of responses was still lower than that observed in the Wt mice on the training dose (Fig. 4c) .
ChAT (IRES) -Cre mice were next tested for nicotine selfadministration. Stable preference for the active, nicotine infusion-associated lever was found for the Wt/Wt, Tg/Wt, and Tg/Tg mice across sessions on the standard 0.03 mg/kg/infusion training dose of nicotine (Fig. 5a-c, respectively) . When data were examined across the last 3 d of acquisition, all groups exhibited significantly increased responding on the active lever, with no differences across groups ( Fig. 5d ; two-way repeatedmeasures ANOVA: Genotype: F (2,28) ϭ 0.27, p ϭ 0.764; Lever: F (1,28) ϭ 29.11, p ϭ 0.000; Interaction: F (1,28) ϭ 0.02, p ϭ 0.984).
Finally, both mouse lines were examined for intravenous nicotine self-administration across a range of doses to assess the dose-response function (Fig. 6) . Whereas the ChAT (BAC) -Cre Wt mice exhibited a dose-response function similar to that demonstrated for mice on a C57BL/6J background (Fowler and Kenny, 2011) , the ChAT (BAC) -Cre Tg mice exhibited a flattened and lowered dose-response function ( Fig. 6a ; two-way repeatedmeasures ANOVA: Genotype: F (1,15) ϭ 11.56, p ϭ 0.004, Dose: F (4,60) ϭ 14.22, p ϭ 0.000, Interaction: F (4,60) ϭ 4.05, p ϭ 0.006). Post hoc analysis revealed significant genotype differences at the lower and moderate levels of nicotine, including the 0.01 ( p Ͻ 0.05), 0.03 ( p Ͻ 0.01), and 0.1 ( p Ͻ 0.01) doses. It should also be noted that the groups did not differ at the saline level of responding, indicating a similar overall baseline level of lever pressing activity. In contrast, ChAT (IRES) -Cre Wt/Wt, Tg/Wt, and Tg/Tg mice did not differ in their responses across doses ( Fig. 6b ; twoway repeated-measures ANOVA: Genotype: F (2,13) ϭ 0.07, p ϭ 0.934; Dose: F (4,52) ϭ 20.15, p ϭ 0.000; Interaction: F (8,52) ϭ 0.25, p ϭ 0.978), with mice exhibiting a typical dose-response function with statistically significant preference for the 0.03 and 0.1 mg/ kg/infusion doses of nicotine compared with saline in post hoc analyses ( p Ͻ 0.05).
Cre expression in the brain
To examine cre expression levels across genotypes, each mouse line was crossed with reporter mice expressing floxed tdTomato. This strategy allowed for the selective expression of red fluorescence in brain cells expressing cre under the ChAT promotor. The medial septum and hippocampus, brain regions implicated in cholinergic function, learning, and memory, and nicotine's actions, were examined under identical microscopy conditions. ChAT (BAC) -Cre::ROSA 26Sor -tdTomato Tg mice exhibited moderately high levels of cre expression in both the septum and hip- pocampus, as evidenced by tdTomato fluorescence, whereas no detectable expression was found in ChAT (BAC) -Cre Wt littermates positive for the ROSA 26Sor -tdTomato gene insert (Fig.  7a,c) . ChAT (IRES) -Cre::ROSA 26Sor -tdTomato Tg/Tg mice exhibited very high levels of cre expression in both the septum and hippocampus (Fig. 7b,d ). ChAT (IRES) -Cre::ROSA 26Sor -tdTomato Tg/Wt mice exhibited an intermediate level of expression in these brain regions, whereas no detectable expression was found in mice lacking the ChAT (IRES) -Cre transgene (e.g., Wt/Wt littermates of ChAT (IRES) -Cre with the ROSA 26Sor -tdTomato gene insert; Fig. 7b,d ).
To further validate the level of cre expression in the brain, brain tissue derived from ChAT (BAC) -Cre and ChAT (IRES) -Cre mice were examined for cre expression with RT-qPCR. In the septum and hippocampus of ChAT (BAC) -Cre mice, expression of cre was detected in the Tg, but not the Wt, brain tissue [ Fig. 8a,b ; unpaired t test: t (8) ϭ 2.64, p ϭ 0.030, R 2 ϭ 0.465 (septum); unpaired t test: t (8) ϭ 3.16, p ϭ 0.013, R 2 ϭ 0.556 (hippocampus)]. In the ChAT (IRES) -Cre mice, significant differences in cre expression were found between groups in the septum ( Fig. 8c ; one-way ANOVA: F (2,32) ϭ 6.42, p ϭ 0.005, R 2 ϭ 0.307). The post hoc test revealed a statistically significant increase in the Tg/Tg mice compared with the Wt/Wt and Tg/Wt groups ( p Ͻ 0.01 and p Ͻ 0.05, respectively). In the hippocampus, similar differences between groups were also documented ( Fig. 8d ; one-way ANOVA: F (2,30) ϭ 10.47, p ϭ 0.000, R 2 ϭ 0.437). Post hoc analyses revealed a significant increase in expression for both the Tg/Wt and Tg/Tg groups compared with the Wt/Wt mice ( p Ͻ 0.01 and p Ͻ 0.001, respectively).
Protein expression of VAChT and ChAT in the hippocampus
Given that the hippocampus receives dense innervation of axonal projections from cholinergic brain regions, including the medial septum, we next examined for altered protein expression of VAChT and ChAT, both of which are enriched in the cholinergic presynaptic terminals in the hippocampus (Frotscher and Léránth, 1985; Gilmor et al., 1996; Schäfer et al., 1998) . Western analyses revealed that the ChAT (BAC) -Cre Tg mice had significantly increased VAChT expression compared with Wt littermates ( Fig. 9a ; unpaired t test: t (20) ϭ 1.97, p ϭ 0.032, R 2 ϭ 0.162), whereas differences were not found between ChAT (IRES) -Cre groups ( Fig. 9b ; one-way ANOVA: F (2,29) ϭ 1.26, p ϭ 0.300). Differences in protein expression of ChAT paralleled the differences found with VAChT for the ChAT (BAC) -Cre mice, with a significant increase in ChAT expression in Tg mice compared with Wt littermates ( Fig. 9c ; unpaired t test: t (26) ϭ 5.50, p ϭ 0.000, R 2 ϭ 0.537). Unexpectedly, significantly decreased ChAT protein expression was found in the ChAT (IRES) -Cre Tg/Tg mice compared with both the Tg/Wt and Wt/Wt mice ( Fig. 9d ; one-way ANOVA: F (2,28) ϭ 32.11, p ϭ 0.000, R 2 ϭ 0.696).
Discussion
In the current studies, significant differences in baseline and nicotine-mediated behavioral profiles were found in two different ChAT-Cre transgenic mouse lines. These behavioral differences were paralleled by altered expression of cholinergic signaling factors. Specifically, whereas the ChAT (BAC) -Cre transgenic (Tg), and wild-type (Wt) mice did not differ in generalized locomotor, anxiety-related behavior, nicotine-induced hypolocomotion, drug-induced cataplexy, or operant food training, behavioral differences were found with intravenous nicotine selfadministration, in which the ChAT (BAC) -Cre Tg mice exhibited a lowered and flattened dose-response function compared with Wt littermates. In contrast, ChAT (IRES) -Cre transgenic (Tg/Tg) mice exhibited decreased locomotor behavior, attenuated operant food training, and resistance to nicotine-induced hypolocomotion, but no difference in intravenous nicotine self-administration or drug-induced cataplexy, compared with wild-type (Wt/Wt) and hemizygous (Tg/Wt) littermates. Finally, altered expression of cre, VAChT, and ChAT were documented, evidence which provides a mechanistic basis for the phenotypes exhibited.
Considerations based on method of genetic manipulation
In generating the ChAT (BAC) -Cre line, multiple copies of the construct were randomly integrated into genomic DNA to target cre expression GENSAT, 2017 (Ting and Feng, 2014 
